BioCardia, Inc.
BCDA
$1.10
-$0.01-0.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 16.55% | 7.34% | -3.55% | -10.59% | -2.75% |
| Total Depreciation and Amortization | -72.92% | -75.00% | -64.18% | -50.00% | -37.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -21.87% | -26.05% | -19.76% | -0.28% | 0.52% |
| Change in Net Operating Assets | -57.05% | 28.27% | 84.45% | 107.49% | -436.87% |
| Cash from Operations | 9.00% | 6.23% | 5.71% | -0.93% | -16.97% |
| Capital Expenditure | -125.00% | -66.67% | -16.67% | 60.00% | -33.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -125.00% | -66.67% | -16.67% | 60.00% | -33.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 32.72% | -6.35% | -17.60% | -26.39% | 92.38% |
| Repurchase of Common Stock | -40.71% | -40.71% | -40.71% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.85% | 13.24% | 25.72% | 41.03% | -113.61% |
| Cash from Financing | 36.00% | -6.15% | -17.38% | -25.69% | 86.41% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 811.34% | -- | -90.14% | -88.47% | 84.71% |